Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Investigational ADC Ups Survival in Advanced Triple-Negative Breast Cancer

Investigational ADC Ups Survival in Advanced Triple-Negative Breast Cancer
ShareXFacebook

(MedPage Today) -- CHICAGO -- Treatment with investigational izalontamab brengitecan (iza-bren) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with unresectable locally advanced or metastatic triple...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

PCOS Was Rebranded As PMOS. We Have Reservations.
MedPage Today

PCOS Was Rebranded As PMOS. We Have Reservations.

(MedPage Today) -- The name of a condition that affects between 6-10% of all reproductive-age women was recently changed from PCOS (polycystic ovary syndrome) to PMOS (polyendocrine metabolic ovarian syndrome) by an international consensus process...

Read more →
Advertisement